Ronidazole in the treatment of trichomonad infections in cats

Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas fo...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutical compounding Vol. 10; no. 6; pp. 434 - 435
Main Author Davidson, Bs Rph Fsvhp Dicvp, Gigi S
Format Journal Article
LanguageEnglish
Published United States International Journal of Pharmaceutical Compounding 01.11.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas foetus had not been idnetified. Since recommended dosages of antimicrobial drugs have failed in cats infected with Tritrichomonas foetus and in vitro studies have revealed multiple drug resistance, investigations continue in the effort to find an effective treatment. One particular study by Dr.Jody Gookin noted no clinicopathological abnormalities or adverse effects with the use of ronidazole, and the research concluded that ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foetus in cats. Clinical use of ronidazole has revealed a reversible, possibly dose-related, neurotoxicity. Cats receiving ronidazole should be monitored for signs of nystagmus, ataxia, or behavior change, and ronidazole should be discontinued immediately if any of these signs are observed. Many compounding pharmacists have begun stocking pure ronidazole powder to prepare veterinarian prescriptions for the treatnment of Tritrichomonas foetus. Doses of ronidazole are usually prepared as capsules, the most desirable dosage form because (1)the capsules mask the extremely bitter taste of ronidazole, (2)exact dosing reduces the risk of neurotoxicity that has been reported at higher doses, and (3)the owner can be assured that the entire dose is ingested by the cat after administration of a capsule.
AbstractList Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas foetus had not been idnetified. Since recommended dosages of antimicrobial drugs have failed in cats infected with Tritrichomonas foetus and in vitro studies have revealed multiple drug resistance, investigations continue in the effort to find an effective treatment. One particular study by Dr.Jody Gookin noted no clinicopathological abnormalities or adverse effects with the use of ronidazole, and the research concluded that ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foetus in cats. Clinical use of ronidazole has revealed a reversible, possibly dose-related, neurotoxicity. Cats receiving ronidazole should be monitored for signs of nystagmus, ataxia, or behavior change, and ronidazole should be discontinued immediately if any of these signs are observed. Many compounding pharmacists have begun stocking pure ronidazole powder to prepare veterinarian prescriptions for the treatnment of Tritrichomonas foetus. Doses of ronidazole are usually prepared as capsules, the most desirable dosage form because (1)the capsules mask the extremely bitter taste of ronidazole, (2)exact dosing reduces the risk of neurotoxicity that has been reported at higher doses, and (3)the owner can be assured that the entire dose is ingested by the cat after administration of a capsule.
Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas foetus had not been identified. Since recommended dosages of antimicrobial drugs have failed in cats infected with 'Tritrichomonas foetus and in vitro studies have revealed multiple drug resistance, investigations continue in the effort to find an effective treatment. One particular study by Dr. Jody Gookin noted no clinicopathological abnormalities or adverse effects with the use of ronidazole, and the research concluded that ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foectus in cats. Clinical use of ronidazole has revealed a reversible, possibly dose-related, neurotoxicity. Cats receiving ronidazole should be monitored for signs of nystagmus, ataxia, or behavior change, and ronidazole should be discontinued immediately if any of these signs are observed. Many compounding pharmacists have begun stocking pure ronidazole powder to prepare veterinarian prescriptions for the treatment of Tritrichomonas foetus. Doses of ronidazole are usually prepared as capsules, the most desirable dosage form because (1) the capsules mask the extremely bitter taste of ronidazole, (2) exact dosing reduces the risk of neurotoxicity that has been reported at higher doses, and (3) the owner can be assured that the entire dose is ingested by the cat after administration of a capsule. [PUBLICATION ABSTRACT]
Author Davidson, Bs Rph Fsvhp Dicvp, Gigi S
Author_xml – sequence: 1
  givenname: Gigi S
  surname: Davidson, Bs Rph Fsvhp Dicvp
  fullname: Davidson, Bs Rph Fsvhp Dicvp, Gigi S
  organization: North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23974416$$D View this record in MEDLINE/PubMed
BookMark eNpd0E1LxDAQBuAgK-6H_gUpnrwUMvloNgcPsugqLAii55ImE7ZLm6xNetBfb8X14mlmeB-GYZZkFmLAM7IALXgpGeOzqaealYIxmJNlSgdKGVcVvSBzxrUSAqoFuXuNoXXmK3ZYtKHIeyzygCb3GHIR_TS0dh_7GIybco82tzGkH2pNTpfk3Jsu4dWprsj748Pb5qncvWyfN_e78giS59IasJUXjVLoqGwobbww0jMtqJRyTbl24KyWAhohGu_RIOhKO14ZAQYMX5Hb373HIX6MmHLdt8li15mAcUw1KKYqyaRmE735Rw9xHMJ0Xc2AUa5gDRO6PqGx6dHVx6HtzfBZ__2FfwOMKGBR
ContentType Journal Article
Copyright Copyright International Journal of Pharmaceutical Compounding Nov/Dec 2006
Copyright_xml – notice: Copyright International Journal of Pharmaceutical Compounding Nov/Dec 2006
DBID NPM
3V.
7RV
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
S0X
7X8
DatabaseName PubMed
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
DatabaseTitle PubMed
SIRS Editorial
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
SIRS Editorial
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1943-5223
EndPage 435
ExternalDocumentID 1177665371
23974416
Genre Journal Article
Feature
GroupedDBID ---
29J
3V.
5GY
7RV
7X7
88E
8AO
8FI
8FJ
8FW
8R4
8R5
AAWTL
AAYOK
ABUWG
ACGFO
ADBBV
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BKEYQ
BPHCQ
BVXVI
CCPQU
EBS
EJD
EX3
FYUFA
HMCUK
LSO
M1P
NAPCQ
NPM
P2P
PQQKQ
PROAC
PSQYO
Q2X
RWL
RXW
S0X
SJN
TAE
UKHRP
WOW
YCJ
ZGI
ZT4
7XB
8FK
ALIPV
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-p153t-ca1c6f4b77ed05b00bf4a5f29405558039d1dc9541b44bffeae1969d36a41a1a3
IEDL.DBID BENPR
ISSN 1092-4221
IngestDate Fri Aug 16 10:28:21 EDT 2024
Fri Sep 13 04:07:52 EDT 2024
Thu May 23 23:18:05 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p153t-ca1c6f4b77ed05b00bf4a5f29405558039d1dc9541b44bffeae1969d36a41a1a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23974416
PQID 212037181
PQPubID 32986
PageCount 2
ParticipantIDs proquest_miscellaneous_1727652592
proquest_journals_212037181
pubmed_primary_23974416
PublicationCentury 2000
PublicationDate 2006 Nov-Dec
20061101
PublicationDateYYYYMMDD 2006-11-01
PublicationDate_xml – month: 11
  year: 2006
  text: 2006 Nov-Dec
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Edmond
PublicationTitle International journal of pharmaceutical compounding
PublicationTitleAlternate Int J Pharm Compd
PublicationYear 2006
Publisher International Journal of Pharmaceutical Compounding
Publisher_xml – name: International Journal of Pharmaceutical Compounding
SSID ssj0023760
Score 1.6923364
Snippet Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 434
SubjectTerms Antibiotics
Diarrhea
Drinking water
Drug resistance
Drug therapy
Title Ronidazole in the treatment of trichomonad infections in cats
URI https://www.ncbi.nlm.nih.gov/pubmed/23974416
https://www.proquest.com/docview/212037181/abstract/
https://search.proquest.com/docview/1727652592
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La8JAEB58XHopfdfayhaKJ4PZzSYxh1Ja0dpCRUTBW9jNbkAoiW3iwf767sSop_YYEnLY2Z395vF9A_DAbdUT0mGWYiZc5SLilsREvu2YEMjAC09SJCd_jL3RnL8v3EUFXndcGGyr3PnEwlGrNMIcede4WFSX69GukJgEiPLu0-rLwvFRWGYtZ2lUoc4ox3pt_WUwnkz3sRf2fhSFz4BZnDH6N6AsLpbhCRyXiJA8b014ChWdnEF7spWU3nTI7MCQyjqkTSYHsenNOTxOzaFU4if91GSZEAPnyGzXO07S2DwscRyKwduKvJWNV0mGn_ZFnl3AfDiY9UdWORLBWhnXlFuRoJEXc-n7WtmuOTIy5sKNWcAL4S7bCRRVUeByKjmXcayFRv0b5XiCU0GFcwm1JE30NRDHQ90b4Qs_DrgwQFGzSPOeErb2kE_bgOZuhcJyX2fh3goNuN-_NRsSqwwi0ek6CxERea6JqlgDrrYLG662yhkhM-jH4C_v5t9_N-GoSHQUjL9bqOXfa31nrv5ctqDqL_xWadxfdKexMQ
link.rule.ids 315,786,790,12083,21416,31754,31755,33779,33780,43345,43840,74102,74659
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEN4oHvRifIv4WBPDicbuo1t6MMYQCSgQYkrCrdntbhMS06ItB_z1zpYCJz02bXqY3Z39ZuabbxB64K5uS8WooymEq1zG3FE2ke8yCIEAXghFbHPycCR6E_429aYVNyevaJVrn1g6ap3FNkf-CC7Wqsu1yfP8y7FDo2xxtZqgsYv2OGPcMvr86TbesnyPstgZUIdTSv4GkeVl0j1ChxUKxC-rZTtGOyY9Qc3xSkZ62cLhtisqb-EmHm8Fppen6OkDDqKWP9mnwbMUA4TD4ZovjrMEHmZ2BApgbI37Fdkqze2nHVnkZ2jSfQ07Pacag-DMwR0VTixJLBKufN9o14NjohIuvYQGvBTrclmgiY4DjxPFuUoSI43VvNFMSE4kkewc1dIsNZcIM2G1bqQv_STgEsChobHhbS1dI2wPbR011haKqr2cRxvL19H95i1sQltZkKnJFnlkUZDwIJKidXSxMmw0X6llRBQQD2AucfXvv-_Qfi8cDqJBf_TeQAdloqPs-LtGteJ7YW7g6i_UbbnAvxparhc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA86QbyI3875EUF2WlmTpul6EJHp2PwYQzbYraRNAgNpp-0O86_3pc22kx5LSw95ycvvvfd7v4fQHXNlR8QedSSFcJWJhDmxSeS7HoRAAC94TExz8vuQ9yfsZepPraRQbmmVK59YOmqZJSZH3gYXa9TlOqStLSti9NR7mH85ZoCUKbTaaRrbaAcuSdcMMwimm9jLcD_KwmdIHUYp-RtQlhdL7wDtW0SIHysTHqItlR6h5qiSlF628HjTIZW3cBOPNmLTy2N0_wGHUoqf7FPhWYoBzuHxijuOMw0PMzMOBfC2xANLvEpz82lXFPkJmvSex92-Y0ciOHNwTYWTCJJwzeIgUNL14cjEmglf05CVwl2uF0oik9BnJGYs1loJZfRvpMcFI4II7xTV0ixV5wh73OjeiEAEOmQCgKKiiWIdKVzFTT9tHTVWKxTZfZ1HayvU0e36LWxIU2UQqcoWeWQQEfchqqJ1dFYtbDSvlDMiCugH8Be_-PffN2gXbBu9DYavDbRX5jzK5r9LVCu-F-oKUEARX5f2_QXZ0bJD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ronidazole+in+the+treatment+of+trichomonad+infections+in+cats&rft.jtitle=International+journal+of+pharmaceutical+compounding&rft.au=Davidson%2C+Bs+Rph+Fsvhp+Dicvp%2C+Gigi+S&rft.date=2006-11-01&rft.issn=1092-4221&rft.eissn=1943-5223&rft.volume=10&rft.issue=6&rft.spage=434&rft_id=info%3Apmid%2F23974416&rft.externalDocID=23974416
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1092-4221&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1092-4221&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1092-4221&client=summon